Carly Weinstein, a 28-year-old content creator, has recently shared her journey with weight loss drugs, shedding light on a personal struggle that many may find relatable. In a candid TikTok video released on April 28, she opened up about her use of GLP-1 medication this year, revealing that she had previously felt too ashamed to discuss her experiences online.
:max_bytes(150000):strip_icc():format(jpeg)/carly-weinstein-1-042926-c183da2dd6de47109c85f6db812c0404.jpg)
Weinstein, who has built a following of over 800,000 across social media platforms, reflected on her former identity as a body positivity advocate. She admitted to feeling compelled to seek treatment after experiencing discomfort and dissatisfaction with her body following weight gain. This was particularly challenging for her, as she felt that her role as an influencer made it difficult to acknowledge her struggles with body image.


During her TikTok narration, Weinstein mentioned a history of disordered eating, which she has worked to address over the years. She explained that after discontinuing stimulant medication while pursuing her master’s degree in social work, she faced significant weight gain, prompting her to turn to GLP-1s as a solution for what she perceived as a loss of control over food and emotional eating.
Although Weinstein clarified that she had never been classified as obese, she described her feelings of unhappiness as her clothing no longer fitted. She felt external pressures from social media and personal interactions that compounded her insecurities, with comments from others labelling her as “overweight,” which ultimately influenced her decision to explore weight loss therapies.
Her experience with GLP-1 medication took an unexpected turn. Weinstein highlighted that she started on a compounded version of GLP-1, a drug not approved by the FDA, given that it does not undergo the same scrutiny regarding safety or effectiveness as other approved medications. This choice stemmed from her desperation to reclaim a sense of personal agency over her body, despite understanding the risks involved.
Weinstein conveyed her disappointment following her initial positive response to the medication. While she did experience some weight loss, the associated side effects left her feeling unwell and disconnected from her true self. After just a couple of months on the drug, she decided to discontinue its use, recognising the adverse effects far outweighed any benefits.
Reflecting on her feelings of shame regarding seeking external help for weight management, Weinstein expressed sorrow for the emotional toll this has taken on her self-perception. She articulated the societal pressures surrounding weight and the misconception that seeking help signifies weakness or failure. For Weinstein, these feelings were particularly pronounced due to her previous role within the body positive movement.
Today, she feels liberated from the guilt that once overshadowed her understanding of her own body and health. Weinstein’s honesty about her struggles serves as a reminder that vulnerability is a crucial part of the human experience, irrespective of one’s social media persona. As she continues her educational journey and personal growth, her story may resonate with many others grappling with similar issues.
Through her candid discussions, Carly Weinstein aims to foster a deeper understanding of the complexities surrounding body image, mental health, and the implications of medication use for weight loss. Her experience not only challenges the stigma associated with weight management but also encourages a more compassionate dialogue about mental and emotional wellbeing in the context of body positivity.
